President and CEO of Dicerna Pharmaceuticals Inc (30-Year Financial, Insider Trades) Douglas Fambrough (insider trades) bought 5,000 shares of DRNA on 08/10/2021 at an average price of $22.1 a share. The total cost of this purchase was $110,500.
For the complete insider trading history of DRNA, click here
.